Isradipine and Lacidipine: Effects In Vivo and In Vitro on Trypanosoma Cruzi Epimastigotes

Author： Nunez-Vergara L.J.   Squella J.A.   Bollo-Dragnic S.   Marin-Catalan R.   Pino L.   Diaz-Araya G.   Letelier M.E.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.30, Iss.1, 1998-01, pp. : 85-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy of Trypanosoma Cruzi Infections

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 3, 2002-10 ,pp. : 247-254

Bentham Science Publishers

Access to resources Recommend Favorite

Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation

By Sun Mingyu   Sun Jin   He Shuangfeng   Wang Yongjun   Sun Yinghua   Liu Xiaohong   He Zhonggui  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 9, 2012-09 ,pp. : 1099-1106

Informa Healthcare

Access to resources Recommend Favorite

Preparation and in vitro/in vivo Evaluation of Lacidipine by Adsorption onto Fumed Silica Using Supercritical Carbon Dioxide

By  

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1053-1064

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Activity Against Trypanosoma cruzi and Leishmania chagasi Parasites of 2,4-Diaryl 1,2,3,4-Tetrahydroquinoline Derivatives

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 8, 2012-10 ,pp. : 802-808

Bentham Science Publishers

Access to resources Recommend Favorite

Direct Antiatherogenic Activity of Isradipine and Lacidipine on Neointimal Lesions Induced by Perivascular Manipulation in Rabbits

By Donetti E.   Fumagalli R.   Paoletti R.   Soma M.R.  

Pharmacological Research, Vol. 35, Iss. 5, 1997-05 ,pp. : 417-422

Academic Press

Access to resources Recommend Favorite